Search Results - Tan, Eng-Huat
- Showing 1 - 20 results of 22
- Go to Next Page
-
1
-
2
-
3
Hydration effects on the efficacy of the Epidermal growth factor receptor kinase inhibitor afatinib by Kannan, Srinivasaraghavan, Pradhan, Mohan R., Tiwari, Garima, Tan, Wei-Chong, Chowbay, Balram, Tan, Eng Huat, Tan, Daniel Shao-Weng, Verma, Chandra
Published 2017Text -
4
Phase I Study of Oral Vinorelbine in Combination with Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Using Two Different Schedules by Sutiman, Natalia, Zhang, Zhenxian, Tan, Eng Huat, Ang, Mei Kim, Tan, Shao-Weng Daniel, Toh, Chee Keong, Ng, Quan Sing, Chowbay, Balram, Lim, Wan-Teck
Published 2016Text -
5
Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC) by Fong, Pei Yuan, Tan, Sze Huey, Lim, Darren Wan Teck, Tan, Eng Huat, Ng, Quan Sing, Sommat, Kiattisa, Tan, Daniel Shao Weng, Ang, Mei Kim
Published 2019Text -
6
Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases by Tan, Wan-Ling, Ng, Quan Sing, Lim, Cindy, Tan, Eng Huat, Toh, Chee Keong, Ang, Mei-Kim, Kanesvaran, Ravindran, Jain, Amit, Tan, Daniel S. W., Lim, Darren Wan-Teck
Published 2018Text -
7
Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases by Tan, Wan-Ling, Ng, Quan Sing, Lim, Cindy, Tan, Eng Huat, Toh, Chee Keong, Ang, Mei-Kim, Kanesvaran, Ravindran, Jain, Amit, Tan, Daniel S. W., Lim, Darren Wan-Teck
Published 2018Text -
8
Phenotypic and functional alterations of Vγ2Vδ2 T cell subsets in patients with active nasopharyngeal carcinoma by Puan, Kia Joo, Low, John Seng Hooi, Tan, Terence Wee Kiat, Wee, Joseph Tien Seng, Tan, Eng Huat, Fong, Kam Weng, Chua, Eu Tiong, Jin, Chenggang, Giner, José-Luis, Morita, Craig T., Goh, Christopher Hood Keng, Hui, Kam M.
Published 2008Text -
9
Bosutinib inhibits migration and invasion via ack1 in kras mutant non-small cell lung cancer by Tan, Daniel SW, Haaland, Benjamin, Gan, Jia Min, Tham, Su Chin, Sinha, Indrajit, Tan, Eng Huat, Lim, Kiat Hon, Takano, Angela, Krisna, Sai Sakktee, Thu, Minn Minn Myint, Liew, Hoe Peng, Ullrich, Axel, Lim, Wan-Teck, Chua, Boon Tin
Published 2014Text -
10
Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLC by Tan, Eng‐Huat, Lim, Wan‐Teck, Ahn, Myung‐Ju, Ng, Quan‐Sing, Ahn, Jin Seok, Shao‐Weng Tan, Daniel, Sun, Jong‐Mu, Han, May, Payumo, Francis C., McKee, Krista, Yin, Wei, Credi, Marc, Agarwal, Shefali, Jac, Jaroslaw, Park, Keunchil
Published 2018Text -
11
Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma by Chia, Whay-Kuang, Teo, Marissa, Wang, Who-Whong, Lee, Bernett, Ang, Soo-Fan, Tai, Wai-Meng, Chee, Chit-Lai, Ng, Joanna, Kan, Rebecca, Lim, Wan-Teck, Tan, Sze-Huey, Ong, Whee-Sze, Cheung, Yin-Bun, Tan, Eng-Huat, Connolly, John E, Gottschalk, Stephen, Toh, Han-Chong
Published 2014Text -
12
Lipidomic Profiling of Lung Pleural Effusion Identifies Unique Metabotype for EGFR Mutants in Non-Small Cell Lung Cancer by Ho, Ying Swan, Yip, Lian Yee, Basri, Nurhidayah, Chong, Vivian Su Hui, Teo, Chin Chye, Tan, Eddy, Lim, Kah Ling, Tan, Gek San, Yang, Xulei, Yeo, Si Yong, Koh, Mariko Si Yue, Devanand, Anantham, Takano, Angela, Tan, Eng Huat, Tan, Daniel Shao Weng, Lim, Tony Kiat Hon
Published 2016Text -
13
Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb Studies by Passaro, Antonio, de Marinis, Filippo, Tu, Hai-Yan, Laktionov, Konstantin K., Feng, Jifeng, Poltoratskiy, Artem, Zhao, Jun, Tan, Eng Huat, Gottfried, Maya, Lee, Victor, Kowalski, Dariusz, Yang, Cheng Ta, Srinivasa, BJ, Clementi, Laura, Jalikop, Tejaswini, Huang, Dennis Chin Lun, Cseh, Agnieszka, Park, Keunchil, Wu, Yi-Long
Published 2021Text -
14
First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for pat... by Schuler, Martin, Tan, Eng-Huat, O’Byrne, Kenneth, Zhang, Li, Boyer, Michael, Mok, Tony, Hirsh, Vera, Yang, James Chih-Hsin, Lee, Ki Hyeong, Lu, Shun, Shi, Yuankai, Kim, Sang-We, Laskin, Janessa, Kim, Dong-Wan, Arvis, Catherine Dubos, Kölbeck, Karl, Massey, Dan, Märten, Angela, Paz-Ares, Luis, Park, Keunchil
Published 2019Text -
15
Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor–Positive Non–Small Cell Lung Cancer by Saw, Stephanie P. L., Zhou, Siqin, Chen, Jianbin, Lai, Gillianne, Ang, Mei-Kim, Chua, Kevin, Kanesvaran, Ravindran, Ng, Quan Sing, Jain, Amit, Tan, Wan Ling, Rajasekaran, Tanujaa, Lim, Darren W. T., Tan, Aaron, Fong, Kam Weng, Takano, Angela, Cheng, Xin Ming, Lim, Kiat Hon, Koh, Tina, Ong, Boon-Hean, Tan, Eng Huat, Toh, Chee Keong, Skanderup, Anders J., Tan, Sze Huey, Tan, Daniel S. W.
Published 2021Text -
16
Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression by Zhang, Wen Cai, Chin, Tan Min, Yang, Henry, Nga, Min En, Lunny, Declan Patrick, Lim, Edwin Kok Hao, Sun, Li Li, Pang, Yin Huei, Leow, Yi Ning, Malusay, Shanneen Rossellini Y, Lim, Priscilla Xin Hui, Lee, Jeravan Zili, Tan, Benedict Jian Wei, Shyh-Chang, Ng, Lim, Elaine Hsuen, Lim, Wan Teck, Tan, Daniel Shao Weng, Tan, Eng Huat, Tai, Bee Choo, Soo, Ross Andrew, Tam, Wai Leong, Lim, Bing
Published 2016Text -
17
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China by Tu, Hai-Yan, Feng, Jifeng, Shi, Meiqi, Zhao, Jun, Wang, Yuyan, Chang, Jianhua, Wang, Jialei, Cheng, Ying, Zhu, Jing, Tan, Eng-Huat, Li, Kai, Zhang, Yiping, Lee, Victor, Yang, Cheng-Ta, Su, Wu-Chou, Lam, David Chi-Leung, Srinivasa, B. J., Rajappa, Senthil, Ho, Ching-Liang, Lam, Kwok Chi, Hu, Yi, Bondarde, Shailesh Arjun, Liu, Xiaoqing, Tian, Yahui, Xue, Zhiyi, Cseh, Agnieszka, Huang, Dennis Chin-Lun, Zhou, Caicun, Wu, Yi-Long
Published 2022Text -
18
Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase I... by Jain, Amit, Lim, Cindy, Gan, Eugene MingJin, Ng, David Zhihao, Ng, Quan Sing, Ang, Mei Kim, Takano, Angela, Chan, Kian Sing, Tan, Wu Meng, Kanesvaran, Ravindran, Toh, Chee Keong, Loo, Chian Min, Hsu, Anne Ann Ling, Devanand, Anantham, Lim, Chong Hee, Koong, Heng Nung, Koh, Tina, Fong, Kam Weng, Yap, Swee Peng, Kim, Su Woon, Chowbay, Balram, Oon, Lynette, Lim, Kiat Hon, Lim, Wan Teck, Tan, Eng Huat, Tan, Daniel Shao Weng
Published 2015Text -
19
A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lun... by Soh, Sheila X., Siddiqui, Fahad J., Allen, John C., Kim, Go Woon, Lee, Jae Cheol, Yatabe, Yasushi, Soda, Manabu, Mano, Hiroyuki, Soo, Ross A., Chin, Tan-Min, Ebi, Hiromichi, Yano, Seiji, Matsuo, Keitaro, Niu, Xiaomin, Lu, Shun, Isobe, Kazutoshi, Lee, Jih-Hsiang, Yang, James C., Zhao, Mingchuan, Zhou, Caicun, Lee, June-Koo, Lee, Se-Hoon, Lee, Ji Yun, Ahn, Myung-Ju, Tan, Tira J., Tan, Daniel S., Tan, Eng-Huat, Ong, S. Tiong, Lim, Wan-Teck
Published 2017Text -
20
Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing by Nahar, Rahul, Zhai, Weiwei, Zhang, Tong, Takano, Angela, Khng, Alexis J., Lee, Yin Yeng, Liu, Xingliang, Lim, Chong Hee, Koh, Tina P. T., Aung, Zaw Win, Lim, Tony Kiat Hon, Veeravalli, Lavanya, Yuan, Ju, Teo, Audrey S. M., Chan, Cheryl X., Poh, Huay Mei, Chua, Ivan M. L., Liew, Audrey Ann, Lau, Dawn Ping Xi, Kwang, Xue Lin, Toh, Chee Keong, Lim, Wan-Teck, Lim, Bing, Tam, Wai Leong, Tan, Eng-Huat, Hillmer, Axel M., Tan, Daniel S. W.
Published 2018Text